The diagnosis and treatment of primary adrenal lipomatous tumors in Chinese patients: a 31-year follow-up study

Authors

  • Fukang Sun Department of Urology, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China
  • Juping Zhao Department of Urology, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai
  • Xiaolong Jing Department of Pathology, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai
  • Wenlong Zhou Department of Urology, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai
  • Xin Huang Department of Urology, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai
  • Haofei Wang Department of Urology, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai
  • Yu Zhu Department of Urology, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai
  • Fei Yuan Department of Pathology, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai
  • Zhoujun Shen Department of Urology, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai

DOI:

https://doi.org/10.5489/cuaj.977

Keywords:

diagnosis, treatment, adrenal lipomatous tumors

Abstract

Introduction: Adrenal lipomatous tumours (ALTs) are rarely encountered in clinical practice and consequently little is known about their clinical features.

Methods: We analyze the clinical features, diagnosis and treatment of ALTs based on cases presenting at a single centre over a 31-year period. We reviewed clinical data from patients with primary adrenal tumours treated at the Ruijin Hospital, Shanghai between January 1980 and December 2010.

Results: A total of 73 cases of primary ALTs in 22 men and 51 women (mean age 51.1±14.2 years) were reviewed. The ALTs included 65 myelolipomas (89.0%), 3 lipomas (4.1%), 2 angiomyolipomas (2.7%), 2 teratomas (2.7%), and 1 liposarcoma (1.4%). Of the total 73 patients, 24 of them had tumours in the left adrenal gland, 47 in the right gland and 2 had bilateral tumours. In total, 51 patients underwent open surgery and 22 laparoscopic surgery.

Conclusion: Myelolipoma is predominant among the various types of lipomatous adrenal gland tumours; it accounts for about 90% of all cases. Surgery is recommended for tumours ≥3.5 cm in diameter, for all cases of symptomatic tumour, and for cases of teratoma or liposarcoma identified by preoperative imaging.

Downloads

Download data is not yet available.

Author Biographies

Fukang Sun, Department of Urology, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China

Department of Urology, Ruijin Hospital,

Chief doctor

Xiaolong Jing, Department of Pathology, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai

chief doctor

Downloads

Published

2014-03-11

How to Cite

Sun, F., Zhao, J., Jing, X., Zhou, W., Huang, X., Wang, H., Zhu, Y., Yuan, F., & Shen, Z. (2014). The diagnosis and treatment of primary adrenal lipomatous tumors in Chinese patients: a 31-year follow-up study. Canadian Urological Association Journal, 8(3-4), e132–6. https://doi.org/10.5489/cuaj.977

Issue

Vol. 8 No. 3-4 (2014): CUAJ March

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.